Anti-Müllerian Hormone As an Ovarian Reserve Marker in Women with the Most Frequent Muscular Dystrophies

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 Jun 6

PMID 32502004

Citations 2

Authors

Olesja Parmova

Eva Vlckova

Monika Hulova

Livie Mensova

Igor Crha

Petra Stradalova

Eva Kralickova

Lenka Jurikova

Martina Podborska

Radim Mazanec

Ladislav Dusek

Jiri Jarkovsky

Josef Bednarik

Stanislav Vohanka

Iva Srotova

Affiliations

Soon will be listed here.

Abstract

Some muscular dystrophies may have a negative impact on fertility. A decreased ovarian reserve is 1 of the factors assumed to be involved in fertility impairment. AMH (anti-Müllerian hormone) is currently considered the best measure of ovarian reserve.A total of 21 females with myotonic dystrophy type 1 (MD1), 25 females with myotonic dystrophy type 2 (MD2), 12 females with facioscapulohumeral muscular dystrophy (FSHD), 12 female carriers of Duchenne muscular dystrophy mutations (cDMD) and 86 age-matched healthy controls of reproductive age (range 18 - 44 years) were included in this case control study. An enzymatically amplified 2-site immunoassay was used to measure serum AMH level.The MD1 group shows a significant decrease of AMH values (median 0.7 ng/mL; range 0 - 4.9 ng/mL) compared with age-matched healthy controls (P < .01). AMH levels were similar between patients and controls in terms of females with MD2 (P = .98), FSHD (P = .55) and cDMD (P = .60).This study suggests decreased ovarian reserve in women with MD1, but not in MD2, FSHD and cDMD.

Citing Articles

Outcome measures in muscular dystrophy rehabilitation: an ICF content comparison approach to the most commonly used MD scales.

Taranu M, Sebio-Garcia R, Milisenda J, Alejaldre A, Pastor X, Laxe S J Rehabil Med. 2025; 57:jrm40327.

PMID: 39886857 PMC: 11811532. DOI: 10.2340/jrm.v57.40327.

Ovarian response in preimplantation genetic testing for myotonic dystrophy type 1.

Sonigo C, Ranisavljevic N, Guigui M, Anahory T, Mayeur A, Moutou C J Assist Reprod Genet. 2024; 42(1):185-192.

PMID: 39709315 PMC: 11806121. DOI: 10.1007/s10815-024-03324-1.

Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?.

Lupica A, Di Stefano V, Gagliardo A, Iacono S, Pignolo A, Ferlisi S Brain Sci. 2021; 11(3).

PMID: 33801069 PMC: 8004068. DOI: 10.3390/brainsci11030398.

References

Sahu B, Ozturk O, Deo N, Fordham K, Ranierri M, Serhal P . Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I. J Assist Reprod Genet. 2008; 25(1):1-5. PMC: 2582107. DOI: 10.1007/s10815-007-9193-y. View

Srebnik N, Margalioth E, Rabinowitz R, Varshaver I, Altarescu G, Renbaum P . Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy. Reprod Biomed Online. 2014; 29(1):94-101. DOI: 10.1016/j.rbmo.2014.03.013. View

Vazquez J, Pinies J, Martul P, de Los Rios A, Gatzambide S, Busturia M . Hypothalamic-pituitary-testicular function in 70 patients with myotonic dystrophy. J Endocrinol Invest. 1990; 13(5):375-9. DOI: 10.1007/BF03350681. View

La Marca A, Stabile G, Artenisio A, Volpe A . Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod. 2006; 21(12):3103-7. DOI: 10.1093/humrep/del291. View

Feyereisen E, Amar A, Kerbrat V, Steffann J, Munnich A, Vekemans M . Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?. Hum Reprod. 2005; 21(1):175-82. DOI: 10.1093/humrep/dei310. View

Verma I, Sood R, Juneja S, Kaur S . Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility. Int J Appl Basic Med Res. 2013; 2(1):17-9. PMC: 3657979. DOI: 10.4103/2229-516X.96795. View

Broer S, Mol B, Hendriks D, Broekmans F . The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2008; 91(3):705-14. DOI: 10.1016/j.fertnstert.2007.12.013. View

van Helden J, Evliyaoglu O, Weiskirchen R . Has GnRH a direct role in AMH regulation?. Clin Endocrinol (Oxf). 2019; 90(6):827-833. DOI: 10.1111/cen.13967. View

Amanvermez R, Tosun M . An Update on Ovarian Aging and Ovarian Reserve Tests. Int J Fertil Steril. 2016; 9(4):411-5. PMC: 4793161. DOI: 10.22074/ijfs.2015.4591. View

10.

Kelsey T, Wright P, Nelson S, Anderson R, Wallace W . A validated model of serum anti-müllerian hormone from conception to menopause. PLoS One. 2011; 6(7):e22024. PMC: 3137624. DOI: 10.1371/journal.pone.0022024. View

11.

de Vet A, Laven J, de Jong F, Themmen A, Fauser B . Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril. 2002; 77(2):357-62. DOI: 10.1016/s0015-0282(01)02993-4. View

12.

Broer S, Broekmans F, Laven J, Fauser B . Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014; 20(5):688-701. DOI: 10.1093/humupd/dmu020. View

13.

Vander Borght M, Wyns C . Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018; 62:2-10. DOI: 10.1016/j.clinbiochem.2018.03.012. View

14.

Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin S . Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016; 7:10055. PMC: 4729924. DOI: 10.1038/ncomms10055. View

15.

Gracia C, Shin S, Prewitt M, Chamberlin J, Lofaro L, Jones K . Multi-center clinical evaluation of the Access AMH assay to determine AMH levels in reproductive age women during normal menstrual cycles. J Assist Reprod Genet. 2018; 35(5):777-783. PMC: 5984885. DOI: 10.1007/s10815-018-1141-5. View

16.

Fanchin R, Schonauer L, Righini C, Guibourdenche J, Frydman R, Taieb J . Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003; 18(2):323-7. DOI: 10.1093/humrep/deg042. View

17.

Lie Fong S, Visser J, Welt C, de Rijke Y, Eijkemans M, Broekmans F . Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012; 97(12):4650-5. PMC: 3683801. DOI: 10.1210/jc.2012-1440. View

18.

Bedecarrats G, ONeill F, Norwitz E, Kaiser U, Teixeira J . Regulation of gonadotropin gene expression by Mullerian inhibiting substance. Proc Natl Acad Sci U S A. 2003; 100(16):9348-53. PMC: 170921. DOI: 10.1073/pnas.1633592100. View

19.

Florence J, Pandya S, King W, Robison J, Baty J, Miller J . Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther. 1992; 72(2):115-22; discussion 122-6. DOI: 10.1093/ptj/72.2.115. View

20.

Kwee J, Schats R, Mcdonnell J, Themmen A, de Jong F, Lambalk C . Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2007; 90(3):737-43. DOI: 10.1016/j.fertnstert.2007.07.1293. View